Showing results (271-280 of 554) with videos related to
Sort By:
Pageof 56
BJU International|November 25, 2010
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National DatabaseEmmanuel S Antonarakis, Yongmei Chen, Sally I Elsamanoudi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2013
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapyM T Schweizer, X C Zhou, H Wang, et al.Translational Andrology and Urology|October 24, 2025
Tumor mutational burden, gene expression patterns, and immune-cell deconvolution in testicular germ cell tumorsLili Wang, Yun Peng, Dingkun Hou, et al.European Urology|September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate CancerMary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.Frontiers in Oncology|March 12, 2025
Case Report: Prepubertal-type testicular teratoma with local metastasis in a postpubertal patientOlivia C Ghirardelli Smith, Alexander K Tsai, Minghao Zhong, et al.International Orthodontics|July 7, 2026
Diagnosis of wire syndrome: A severity-based classification developed by a Multidisciplinary Working GroupSophie-Myriam Dridi, Sofia Aroca, Gregory S Antonarakis, et al.The Prostate|March 25, 2011
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivationDaniel Keizman, Peng Huang, Emmanuel S Antonarakis, et al.Prostate Cancer and Prostatic Diseases|January 6, 2018
p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancerBenjamin L Maughan, Liana B Guedes, Kenneth Boucher, et al.Endocrinology|February 17, 2024
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early DetectionSong Yi Bae, Kaylee Judith Kamalanathan, Catalina Galeano-Garces, et al.Biochemical and Biophysical Research Communications|October 23, 1997
Immunochemical characterization of a novel mitochondrially located protein encoded by a nuclear gene within the DFNB8/10 critical region on 21q22.3K Krohn, V Ovod, P Vilja, et al.Pageof 56